Axa
LVTX

Axa’s LAVA Therapeutics LVTX Stock Holding History

Axa’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-225,748
Closed -$375K – 1130
2023
Q1 		$375K Sell
225,748
-1,733
-0.8% -$4.85K ﹤0.01% 997
2022
Q4 		$796K Sell
227,481
-1,190
-0.5% -$5.46K ﹤0.01% 923
2022
Q3 		$1.05M Buy
228,671
+1,198
+0.5% +$3.3K ﹤0.01% 853
2022
Q2 		$671K Sell
227,473
-4,413
-2% -$15.3K ﹤0.01% 933
2022
Q1 		$1.02M Buy
231,886
+2
+0% +$10 ﹤0.01% 950
2021
Q4 		$1.27M Buy
231,884
+2,763
+1% +$18.1K ﹤0.01% 918
2021
Q3 		$1.36M Buy
229,121
+8,458
+4% +$60.9K ﹤0.01% 934
2021
Q2 		$2.4M Buy
220,663
+300
+0.1% +$3.72K 0.01% 856
2021
Q1 		$3.35M Buy
+220,363
New +$3.03M 0.01% 769

Other funds holding LVTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return